These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20573564)

  • 1. A transient kinetic approach to investigate nucleoside inhibitors of mitochondrial DNA polymerase gamma.
    Anderson KS
    Methods; 2010 Aug; 51(4):392-8. PubMed ID: 20573564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on the molecular mechanism of inhibition and toxicity of nucleoside analogs that target HIV-1 reverse transcriptase.
    Anderson KS
    Biochim Biophys Acta; 2002 Jul; 1587(2-3):296-9. PubMed ID: 12084471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the molecular mechanism of mitochondrial toxicity by AIDS drugs.
    Feng JY; Johnson AA; Johnson KA; Anderson KS
    J Biol Chem; 2001 Jun; 276(26):23832-7. PubMed ID: 11328813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase.
    Sohl CD; Kasiviswanathan R; Kim J; Pradere U; Schinazi RF; Copeland WC; Mitsuya H; Baba M; Anderson KS
    Mol Pharmacol; 2012 Jul; 82(1):125-33. PubMed ID: 22513406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of enzyme kinetics data for mitochondrial DNA strand termination by nucleoside reverse transcription inhibitors.
    Wendelsdorf KV; Song Z; Cao Y; Samuels DC
    PLoS Comput Biol; 2009 Jan; 5(1):e1000261. PubMed ID: 19132079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
    Painter GR; Almond MR; Mao S; Liotta DC
    Curr Top Med Chem; 2004; 4(10):1035-44. PubMed ID: 15193137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.
    Lim SE; Ponamarev MV; Longley MJ; Copeland WC
    J Mol Biol; 2003 May; 329(1):45-57. PubMed ID: 12742017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the effects of stereochemistry on incorporation and removal of 5-fluorocytidine analogs by mitochondrial DNA polymerase gamma: comparison of D- and L-D4FC-TP.
    Murakami E; Ray AS; Schinazi RF; Anderson KS
    Antiviral Res; 2004 Apr; 62(1):57-64. PubMed ID: 15026203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ.
    Sohl CD; Szymanski MR; Mislak AC; Shumate CK; Amiralaei S; Schinazi RF; Anderson KS; Yin YW
    Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8596-601. PubMed ID: 26124101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3'-fluorothymidine analogue 5'-triphosphates.
    Wińska P; Miazga A; Poznański J; Kulikowski T
    Antiviral Res; 2010 Nov; 88(2):176-81. PubMed ID: 20739003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol.
    Mislak AC; Anderson KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):561-9. PubMed ID: 26552983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.
    von Kleist M; Metzner P; Marquet R; Schütte C
    PLoS Comput Biol; 2012 Jan; 8(1):e1002359. PubMed ID: 22275860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV-1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine.
    Bertoletti N; Chan AH; Schinazi RF; Yin YW; Anderson KS
    Protein Sci; 2019 Sep; 28(9):1664-1675. PubMed ID: 31301259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside-analog resistance mutations in HIV-1 reverse transcriptase and their influence on polymerase fidelity and viral mutation rates.
    Rezende LF; Prasad VR
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1716-34. PubMed ID: 15183340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between antiviral activity and host toxicity: comparison of the incorporation efficiencies of 2',3'-dideoxy-5-fluoro-3'-thiacytidine-triphosphate analogs by human immunodeficiency virus type 1 reverse transcriptase and human mitochondrial DNA polymerase.
    Feng JY; Murakami E; Zorca SM; Johnson AA; Johnson KA; Schinazi RF; Furman PA; Anderson KS
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1300-6. PubMed ID: 15047533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of 2'-deoxyguanosine triphosphate analogue inhibitors of HIV reverse transcriptase with human mitochondrial DNA polymerase gamma.
    Ray AS; Feng JY; Murakami E; Chu CK; Schinazi RF; Anderson KS
    Antivir Chem Chemother; 2007; 18(1):25-33. PubMed ID: 17354649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of interaction of human mitochondrial DNA polymerase γ with the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine indicates a low potential for host toxicity.
    Sohl CD; Singh K; Kasiviswanathan R; Copeland WC; Mitsuya H; Sarafianos SG; Anderson KS
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1630-4. PubMed ID: 22155823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
    Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
    mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic therapeutic index of acyclovir. Viral versus human polymerase gamma specificity.
    Hanes JW; Zhu Y; Parris DS; Johnson KA
    J Biol Chem; 2007 Aug; 282(34):25159-67. PubMed ID: 17573351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.